Results 131 to 140 of about 208,181 (263)

Predicting COVID-19 Infections in Eswatini Using the Maximum Likelihood Estimation Method [PDF]

Int J Environ Res Public Health, 2022
Dlamini SN, Dlamini WM, Socé Fall I.
europepmc   +2 more sources

Performance of Cross-Validated Targeted Maximum Likelihood Estimation. [PDF]

Stat Med
Smith MJ, Phillips RV, Maringe C, Luque-Fernandez MA.   +3 more
europepmc   +1 more source

Maximum Likelihood Estimation for Shape-restricted Single-index Hazard Models. [PDF]

J Data Sci, 2023
Qin J, Sun Y, Yuan A, Huang CY.
europepmc   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Maximum likelihood estimation of spatially dependent interactions in large populations of cortical neurons. [PDF]

Front Comput Neurosci
Godin C, Thivierge JP.
europepmc   +1 more source

The identification of mediating effects using genome-based restricted maximum likelihood estimation. [PDF]

PLoS Genet, 2023
Rietveld CA, de Vlaming R, Slob EAW.
europepmc   +1 more source

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran, Malo Gaubert, Alice Dufey, Elise Bannier, Audrey Rico, Jean‐Christophe Ferré, Raphaël Chouteau, Laure Michel, Emmanuelle Le Page, Virginie Callot, Bertrand Audoin, Sarah Demortière, Benoît Combès, Anne Kerbrat   +13 more
wiley   +1 more source

Better Than Maximum Likelihood Estimation of Model-based and Model-free Learning Styles. [PDF]

Basic Clin Neurosci
Yazdani S, Vahabie AH, Nadjar-Araabi B, Nili Ahmadabadi M.   +3 more
europepmc   +1 more source

Maximum likelihood estimation of difference scaling functions for suprathreshold judgments. [PDF]

J Vis, 2022
Teti ES, Turton TL, Miller JM, Bujack R.
europepmc   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul   +9 more
wiley   +1 more source